Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): April 22, 2016 (April 21, 2016)

 

 

Humana Inc.

(Exact Name of Registrant as Specified in Its Charter)

 

 

Delaware

(State or Other Jurisdiction of Incorporation)

 

1-5975   61-0647538
(Commission File Number)   (IRS Employer Identification No.)
500 West Main Street, Louisville, KY   40202
(Address of Principal Executive Offices)   (Zip Code)

502-580-1000

(Registrant’s Telephone Number, Including Area Code)

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

  ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

  ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

  ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

  ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 5.07 Submission of Matters to a Vote of Security Holders

The regular annual meeting of the stockholders of Humana Inc. was held in Chicago, Illinois, on April 21, 2016, for the purpose of voting on the proposals described below. Proxies for the meeting were solicited pursuant to Section 14(a) of the Securities Exchange Act of 1934 and there was no solicitation in opposition to management’s nominees for directors. All nominees for director listed below were elected. The term of office for each director will be until the next annual meeting or until their successors shall be elected and qualified.

The final results of the election of directors were as follows:

 

Name

  

For

  

Against

  

Abstained

  

Broker Non-Votes

Kurt J. Hilzinger

   120,920,667    919,892    239,938    6,968,688

Bruce D. Broussard

   120,408,186    1,488,806    183,505    6,968,688

Frank A. D’Amelio

   120,289,859    1,293,151    497,487    6,968,688

W. Roy Dunbar

   120,984,192    866,024    230,281    6,968,688

David A. Jones, Jr.

   119,549,457    2,093,457    437,583    6,968,688

William J. McDonald

   121,555,983    285,018    239,496    6,968,688

William E. Mitchell

   119,984,616    1,852,237    243,644    6,968,688

David B. Nash, M.D.

   121,213,625    640,065    226,807    6,968,688

James J. O’Brien

   121,444,836    393,311    242,350    6,968,688

Marissa T. Peterson

   121,242,964    661,451    176,082    6,968,688


In addition, the stockholders voted on the following proposals and cast their votes as described below:

 

Proposal

  

For

  

Against

  

Abstained

  

Broker Non-Votes

The appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2016

   127,965,258    965,478    118,449    0

Board proposal regarding advisory approval of the company’s executive compensation

   117,931,732    3,641,988    506,777    6,968,688


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

 

HUMANA INC.
BY:  

/s/ Cynthia H. Zipperle

  Cynthia H. Zipperle
  Vice President, Chief Accounting Officer and Controller

Dated: April 22, 2016